Corbion
Corbion delivers Sales of € 645.6 million and an improvement of EBITDA margins of +300 bps for first-half 2025; full-year outlook maintained
Corbion delivers Sales of € 645.6 million and an improvement of EBITDA margins of +300 bps for first-half 2025; full-year outlook maintained
Corbion, the Amsterdam-listed sustainable ingredients company that champions preservation through application of science, today publishes its half-year 2025 results ending 30 June 2025.
Key highlights half-year results 2025:
| - Organic sales growth: +2.9% | (Q2: -1.6%) | |
| - Volume/mix: +3.3% | (Q2: -1.3%) | |
| - Price: -0.4% | (Q2: -0.3%) | |
| - Sales € 645.6 million | (Q2: € 315.9 million) | |
| - Adjusted EBITDA: € 106.6 million | (Q2: € 52.2 million) | |
| - Adjusted EBITDA organic growth +29.3% | ||
| - Adjusted EBITDA margins improved +300 bps to 16.5% | ||
| - Operating profit € 63.5 million | ||
| - Volume/mix growth in both business segments | ||
| - Cash flow from operating activities € 45.7 million, Free Cash Flow € 12.1 million | ||
| - FY 2025 outlook maintained | ||
| € million | H1 2025 | H1 2024 | H1 growth | H1 Organic growth | Q2 2025 | Q2 2024 | Q2 growth | Q2 Organic growth | |||||
| Sales | 645.6 | 637.1 | +1.3% | +2.9% | 315.9 | 336.7 | -6.2% | -1.6% | |||||
| Adjusted EBITDA | 106.6 | 86.1 | +23.8% | +29.3% | 52.2 | 51.6 | +1.2% | +12.8% | |||||
| Adj. EBITDA margin | 16.5% | 13.5% | 16.5% | 15.3% | |||||||||
| Operating profit | 63.5 | 33.6 | +89.0% | +100.3% | 29.5 | 22.0 | +34.1% | +55.0% | |||||
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Financière de Tubize SA2.8.2025 08:00:00 CEST | Press release
Financière de Tubize - 2025 half-year financial report
DBV Technologies S.A.1.8.2025 22:05:00 CEST | Press release
Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2025
Mandalay Resources Corporation1.8.2025 21:12:01 CEST | Press release
Mandalay Obtains Final Order Approving Arrangement with Alkane
F. Hoffmann-La Roche Ltd1.8.2025 20:00:00 CEST | Press release
Roche’s Susvimo maintains vision over five years with two refills per year in people with neovascular age-related macular degeneration (nAMD)
KBC Groep1.8.2025 18:10:00 CEST | Press release
KBC Group: KBC remains well-capitalised under 2025 EU-wide EBA stress test
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom